Publications by authors named "R Heath"
Article Synopsis
- Saturated heterocycles are important for drug development but are difficult to synthesize, especially in an asymmetric manner.* -
- The study illustrates the use of imine reductases in tandem processes to create these heterocycles through both inter- and intramolecular reductive amination.* -
- The approach enables the production of various unsubstituted and substituted heterocycles from simple materials in a single reaction under mild conditions, showcasing the versatility of imine reductases.*
Article Synopsis
- * Out of 112 respondents, which included both surgeons and hand therapists, the study found significant variability in surgical decision-making and imaging practices, with most centers favoring ligament reconstruction using a bone anchor.
- * Findings suggest that there is inconsistency in the treatment approaches for UCL ruptures and a strong interest among medical professionals for future clinical trials to standardize management practices.
At the University of Alabama at Birmingham (UAB), many diagnostic and therapeutic procedures involving radioactive materials or radiation-producing machines are performed daily. A growing number of minor but preventable incidents related to radiation safety have brought up concerns related to the effectiveness of the training program. A comprehensive literature review was performed to summarize post-COVID insights into andragogic online training practices, statistical analyses, and overall retention competencies in radiation safety.
View Article and Find Full Text PDFVenous thromboembolism (VTE) in pediatric trauma patients is under-investigated. The purpose of this study was to perform an evaluation of the risk factors for VTE after pediatric trauma, including readmissions across the United States. The Nationwide Readmissions Database for 2016-2020 was queried for all patients under the age of 18 years admitted for trauma.
View Article and Find Full Text PDFPurpose: Factor Xa Inhibitors have emerged as a first-line agent in the management of non-valvular atrial fibrillation (NVAF), but there is a need for additional data surrounding their use in the morbidly obese population. The purpose of this study was to evaluate whether Factor Xa Inhibitors are as safe and effective as warfarin for the treatment of NVAF in individuals with a BMI ≥ 40 kg/m and/or weight ≥ 120 kg.
Methods: This was a multi-center retrospective cohort study comparing the use of Factor Xa Inhibitors (apixaban and rivaroxaban) to warfarin for the management of NVAF in adult patients with a BMI ≥ 40 kg/m and/or weight ≥ 120 kg.